3d druck und health techcpd) cell-compatible printing process bioinktm ……... bioinktm...
TRANSCRIPT
28.08.2014 Health Tech Cluster Switzerland: 3D Druck und Health Tech
Additive Verfahren mit biologischen Materialien
Dr. Markus Rimann Zürcher Hochschule für Angewandte Wissenschaften (ZHAW) Fachgruppe Tissue Engineering
3D Druck und Health Tech
28.08.2014 Health Tech Cluster Switzerland: 3D Druck und Health Tech
Background: 3D Cell Culture
2
Why should we cultivate cells in three-dimensions (3D)? • Humans are 3D
Advantages of 3D cell culture • Cell behavior between 2D and 3D is completely different (Proliferation, differentiation, metabolism) • Different metabolic activity of 2D versus 3D, e.g. higher drug resistance of 3D • Cell communication between cells is decreased in 2D, but crucial.
Drawbacks of current 3D cell culture technologies • Limited control of cell distribution within a 3D system • Integration of blood vessels difficult (to control) (Tissue size limited, O2- and nutrient limitation)
=> Artificial organs difficult
Application in regenerative medicine and drug testing • Provides reliable data • Reduces animal experiments • Accelerates cost-intensive process of drug development
2D cell culture
3D cell culture
Organs on demand Regenerative medicine
Drug testing
High organ structure
complexity
Schematc representation of kidney structure (ww.arizonatransplantassociates .com)
Schematic representation of skin structure (www.intechopen.com)
28.08.2014 Health Tech Cluster Switzerland: 3D Druck und Health Tech 3
Background: Organs on demand
Principle: Layer-by-layer deposition of biological material to produce 3D organotypic in vitro models
Flexibility in 3D shape
Spatial control of cells, matrix and bioactive molecules (growth factors etc.)
Standardized, automated and reproducible process
High-throughput screening
Integration of quality control
Guillotin and Guillemot, 2011 3DDiscovery® bioprinter, regenHU (www.regenhu.com)
Bioprinting
Is the bioprinting technology the solution?
28.08.2014 Health Tech Cluster Switzerland: 3D Druck und Health Tech 4
Standardization of a printing process for the manufacture of soft tissue models
Approved printing device
Cell-compatible bioink
Choice of a soft tissue model as proof of concept
Keratinocytes seeding
Skin
. . . . . . . . . . . . . . . . . . . . .
Fibroblasts in collagen I gel
Contraction
Keratinocytes on top of dermis
Air-lift
Keratinocytes differentiation
Contracted collagen I gel
3DDiscovery®
User-friendly software
Sterile printing conditions
Printing process in standard cell culture devices
3DDiscovery® printer, regenHU
BioInkTM
BioInkTM
cartridge, regenHU
28.08.2014 Health Tech Cluster Switzerland: 3D Druck und Health Tech 5
ZHAW research
28.08.2014 Health Tech Cluster Switzerland: 3D Druck und Health Tech
ZHAW research
6
Bioprinter
• Sterile printing environment • Cell-compatible printheads • User-friendly software (CAD-program) • Flexible system to cope with fast development of this
technology
Bioprinting technologies (Malda et al., 2013, Adv. Mat.)
28.08.2014 Health Tech Cluster Switzerland: 3D Druck und Health Tech
ZHAW research
7
Bioink
• Printable matrix to arrange cells in 3D (universal bioink) • Cell-compatible, cell adhesion, cell migration • Stiffness adjustable (bone, soft tissue) • Fast polymerization (different modes) • Ready-to-use commercial product
Printed structures with bioink (Melchels et al., 2014, J. Mater. Chem. B.)
BioInk™
Dermis equivalent scheme
Human primary fibroblasts printed in BioInkTM
dermis equivalents. Models stained with MTT after 2 days of culture show cell viability and a clear printing pattern
The polymerization process of the matrix at 365nm ± 10nm doesn’t cause DNA damages. ELISA analysis for the detection of cyclobutane pyrimidine dimers (CPD)
Cell-compatible printing process
BioInkTM
BioInkTM ……...
Fibroblasts
ZHAW research
28.08.2014 Health Tech Cluster Switzerland: 3D Druck und Health Tech 8
28.08.2014 Health Tech Cluster Switzerland: 3D Druck und Health Tech
International research
9
Complex tissue structures with “blood vessels” Kolesky, Truby, Gladman, Busbee, Homan, Lewis Wyss Institute for Biologically Inspired Engineering, Harvard University, USA (Adv. Mat., 2014)
Tissue production by extrusion technology (robotic dispensing, slide 6). Left: Principle of a printed construct (ECM: extracellular matrix), right top: Scheme of the printed structure, right bottom: Printed construct with differently colored cell types.
Different bioinks are printed together Different cell types are precisely deposited within a 3D structure Blood vessel printing is feasible (not in one step) Larger tissue constructs are printable because of vasculature integration
28.08.2014 Health Tech Cluster Switzerland: 3D Druck und Health Tech
International research
10
Printed liver
Liver complexity (http://www.cosmiq.de/qa/show/2802267/hat-der-mensch-eine-leber-oder-zwei/)
Printed „liver“ harboring three different cell types. Organovo, San Diego, CA 92121, USA
Three different cell types were printed in the same construct Liver-specific functions were reported Liver complexity not achieved
28.08.2014 Health Tech Cluster Switzerland: 3D Druck und Health Tech
International research
11
Printed kidney
Kidney complexity (http://www.jameda.de/gesundheits-lexikon/niere/)
Printed „kidney“. Atala, Wake Forest Institute for Regenerative Medicine, Winston Salem, NC 27157, USA,
Printed kidney shape harboring cells Kidney complexity not achieved Kidney functionality not achieved
28.08.2014 Health Tech Cluster Switzerland: 3D Druck und Health Tech
Summary
12
• Bioprinting has a huge potential in substance testing and regenerative medicine
• Technology is still in its infancy
Printing of simple structures (resolution?)
• Lack of standardization and reproducibility
Research groups are fabricating their own bioprinters Research groups are synthesizing their own bioinks
• Few commercially-available bioprinters
Technology at high level
• Few commercially-available bioinks
Cell-compatibility is important and difficult to achieve Thorough material characterization is necessary (stiffness, viscosity, degradability)
Bioink properties (Malda et al., 2013, Adv. Mat.)
28.08.2014 Health Tech Cluster Switzerland: 3D Druck und Health Tech
Acknowledgements
Prof. Dr. Ursula Graf-Hausner Dr. Epifania Bono Helene Annaheim Matthias Bleisch Tissue Engineering Team
13
Marc Thurner Michael Kuster Andreas Scheidegger
Danke für Ihre Aufmerksamkeit